Is BMC (BioMed Central) Peer Reviewed & Legit?

Yes. BMC — BioMed Central — is a large, well-established open-access publisher whose journals use genuine editorial peer review before publication, and whose titles are comprehensively indexed in PubMed/MEDLINE, Scopus, and Web of Science. BMC has been part of Springer Nature since Springer acquired it in 2008, and Springer itself merged with Nature Publishing Group’s parent company in 2015 to form Springer Nature. The “is BMC peer reviewed” search is common not because BMC’s legitimacy is genuinely in doubt, but because the name — BioMed Central, rather than a recognizable single-journal title — reads as unfamiliar or generic to a researcher encountering it for the first time, the same dynamic that drives similar searches for MDPI, Frontiers, and Cureus.

What BMC Is

BioMed Central was founded in 2000 as the first for-profit open-access science publisher, built on the then-novel idea of funding publication through article processing charges (APCs) rather than reader subscriptions. Springer Science+Business Media acquired BMC in October 2008; BMC continued to operate as a distinct publishing brand within Springer, and remained so when Springer merged with Macmillan Science and Education (parent of Nature Publishing Group) in 2015 to form Springer Nature. BMC is not a single journal — it’s a publishing group encompassing several hundred peer-reviewed, open-access journals across medicine, biology, and related sciences, published under the BMC series naming convention (BMC Medicine, BMC Public Health, BMC Bioinformatics, and so on), plus a number of other Springer Nature open-access titles it publishes on behalf of societies and institutions.

How BMC’s Peer Review Process Works

BMC journals use standard pre-publication editorial peer review: submissions are assessed by an academic editor and independent expert reviewers before an acceptance decision, following the same general structure described in CASRAI’s peer review entry. What sets BMC apart historically is its role in open peer review: in 2001, BioMed Central became the first publisher to post named reviewer reports alongside published articles for its medical journals, as part of what it called a “pre-publication history.” Many BMC series medical journals still operate this way today — reviewer identities are disclosed to authors and, on publication, reviewer reports are published alongside the article rather than kept confidential. Not every BMC journal uses fully open review; policies vary by individual title, and each journal publishes its own peer-review policy on its submission-guidelines page (for example, BMC Medicine‘s and BMC Health Services Research‘s policies are both published individually). Because BMC operates as a large group of separately edited journals rather than one editorial operation, the right way to confirm the review model for any specific BMC title is to check that journal’s own “Peer-review policy” page, not to assume every BMC journal uses an identical process.

Why People Ask If BioMed Central Is Legit

Most searches for “is BioMed Central legit” trace back to one documented episode rather than to vague unease. In March 2015, BioMed Central retracted 43 papers after an investigation into fabricated peer review. Third-party agencies selling submission and language-editing services had supplied invented reviewer identities and contact addresses, so review requests were routed back to the agency instead of to a real academic; around 50 papers were examined in total, and a further set of already-rejected submissions appeared connected to the same scheme. BMC’s senior editor at the time, Elizabeth Moylan, attributed the manipulation to those third-party agencies, and BMC responded by disabling the submission-system function that let authors enter reviewer contact details directly, instructing editors to verify suggested reviewers’ identities and to prefer institutional email addresses.

That episode is now a decade old, and three things about it matter more than the headline. First, the vulnerability exploited — author-supplied reviewer contact details — was an industry-wide weakness of submission systems in that period, not a BMC-specific absence of peer review; several major publishers were hit by variants of the same scam. Second, BioMed Central detected it, disclosed it, retracted the affected papers publicly and closed the loophole, which is the behaviour of a functioning editorial process rather than a predatory one. A predatory publisher has no review process to compromise in the first place, and therefore never retracts anything. Third, the fact that a fake reviewer had to be smuggled in at all establishes that genuine review was the norm being subverted. None of this makes the episode irrelevant when you are assessing a specific paper from that era, but it is not evidence that BioMed Central lacks peer review today.

A second and weaker driver is the name itself. Researchers encountering an unfamiliar publisher name, especially one built from generic-sounding words (“BioMed,” “Central”), rather than a recognizable proper noun, reasonably want to verify it before submitting or citing. That instinct is sound in general — it’s the same instinct that should be applied to any unfamiliar journal, per CASRAI’s guide to identifying predatory journals and publishers. But in BMC’s specific case, the concern doesn’t hold up against the record: BMC discloses its editorial process and business model openly, its journals are edited by named academic editorial boards, and its indexing footprint (below) is exactly what a genuinely predatory operation typically cannot achieve, because predatory journals are, by definition, rejected from or never accepted into selective indexes precisely because they lack real peer review. BMC’s generic-sounding name is a naming-convention artifact of when it was founded (2000, before “BioMed Central”-style names became associated with less scrupulous open-access operations that later copied the APC-funded model without the underlying editorial rigor) — not evidence of anything about its editorial practices.

Indexing Status

BMC journals are broadly indexed across the databases researchers and institutions rely on to screen for legitimacy:

PubMed/MEDLINE — BMC’s medicine- and health-science-focused titles (e.g. BMC Medicine, BMC Public Health) are indexed in MEDLINE, the National Library of Medicine’s selective, quality-screened index.
Scopus — BMC journals are indexed in Elsevier’s Scopus database.
Web of Science — BMC’s major titles are indexed in Clarivate’s Science Citation Index Expanded / Web of Science Core Collection and carry a Journal Impact Factor.

As with any large multi-journal publisher, indexing status is set at the individual-journal level, not the publisher level — a newer or more specialized BMC title may not yet carry all three, so it’s worth checking a specific journal’s own indexing statement rather than assuming the whole group is indexed uniformly. That said, broad, verifiable indexing across these selective databases is itself a strong legitimacy signal, since none of the three accepts or retains journals without a demonstrated peer-review process.

Indexing is also revocable rather than permanent: Clarivate and Elsevier both re-evaluate titles on a rolling basis and remove those that stop meeting their criteria, so what matters is whether a journal is indexed now, not whether it once was — see CASRAI’s guide to why journals get delisted from Web of Science.

BioMed Central Does Not Have a Single Impact Factor

A common follow-up to “is BioMed Central legit” is “what is BioMed Central’s impact factor,” and the honest answer is that there is no such number. The Journal Impact Factor is calculated by Clarivate for an individual journal, not for a publisher, and BioMed Central publishes several hundred journals. Individual BMC titles indexed in the Web of Science Core Collection each carry their own Impact Factor, and those figures differ from one another by a wide margin; there is no publisher-level figure that averages them, and any site quoting one number as “the BioMed Central impact factor” has invented it. The same correction applies to every large multi-journal publisher — CASRAI’s guide to Hindawi journal impact factors covers the identical confusion at a different publisher. To find the current figure for a specific BMC title, look that exact journal up in Clarivate’s Journal Citation Reports or on the journal’s own “About” page, and note which year the figure refers to.

Article Processing Charges and Fee Transparency

BioMed Central is fully open access and funds publication through article processing charges (APCs) paid by authors, their funders, or their institutions, rather than through reader subscriptions. This is the model BMC pioneered in 2000, and paying to publish is not in itself a predatory signal — it is how open access works. APCs are set per journal rather than per publisher, and each BMC journal publishes its own current charge on its own site, before submission. Fee transparency is one of the clearest practical dividing lines between a legitimate APC-funded publisher and a predatory one: the warning sign is never that a journal charges, but that the charge is undisclosed until after acceptance, differs from the advertised amount, or is demanded before any review has taken place. Many institutions also hold open-access agreements with Springer Nature that cover or discount BMC APCs for their corresponding authors, so it is worth checking with your library before paying one personally.

Is BMC a Predatory Publisher?

No, by the standard definition used across the field — see CASRAI’s predatory journal entry. A predatory journal is characterized by the absence of genuine peer review behind an APC-funded business model, typically paired with deceptive claims about editorial boards, indexing, or fees. BMC does not fit that pattern: it discloses its editorial and peer-review processes openly (down to publishing individual journals’ review policies and, for many titles, the reviewer reports themselves), its business model (APC-funded open access) is stated plainly rather than concealed, and its indexing in PubMed/MEDLINE, Scopus, and Web of Science is real and independently verifiable. BMC is part of Springer Nature, itself a member of COPE (Committee on Publication Ethics), OASPA (Open Access Scholarly Publishing Association), and STM, the major cross-publisher trade and standards bodies whose membership requires publicly committing to their codes of conduct. None of this means every BMC journal or every BMC-published article is beyond scrutiny — APC-funded high-volume open access as a model has drawn broader industry debate over incentives and review rigor, a debate that also touches other large OA publishers like MDPI and Frontiers — but that is a different, more nuanced question than “is BMC peer reviewed,” and the evidence does not support treating BMC as a predatory operation.

Set side by side against the standard predatory-publisher warning signs, the contrast is not marginal:

Check	BioMed Central	Typical predatory publisher
Peer review	Pre-publication review by an academic editor plus independent reviewers; many titles publish the reviewer reports themselves	Nominal or absent; acceptance within days, with no substantive reviewer comments
Ownership	Springer Nature, disclosed openly, with a verifiable corporate history since 2008	Undisclosed, or a shell entity with no verifiable address or ownership trail
Editorial board	Named editors-in-chief and board members with institutional affiliations	Names listed without consent, unreachable, or fabricated outright
Indexing	Independently verifiable per journal in PubMed/MEDLINE, Scopus and the Web of Science Master Journal List	Claims indexing the index itself does not confirm; cites invented metrics
Fees	APC published per journal, before submission	Fee revealed only after acceptance, or different from the advertised amount
Retractions	Issues and publicly labels retractions, including against its own record, as in 2015	Never retracts; problems simply remain in the literature

Evaluating an Individual BMC Journal, Not Just the Publisher

Confirming BMC’s legitimacy as a publisher answers “is this operation real and above-board” — it does not mean every one of BMC’s several hundred journals sits at the same level of selectivity, editorial engagement, or citation impact. That’s true of any large multi-journal publisher, not a BMC-specific weakness: Springer Nature, Elsevier, Wiley, and Taylor & Francis each publish some journals with decades of prestige alongside others that are newer, narrower in scope, or more specialized. Before submitting to or citing a specific BMC title, check the individual journal rather than relying on the publisher’s overall reputation:

That journal’s own peer-review policy page — BMC does not run one uniform review process across all titles; each journal states its own model (open peer review, single-anonymized, etc.) and typical review timeline on its own site.
That journal’s specific indexing status — check PubMed/MEDLINE, Scopus, and the Web of Science Master Journal List for the exact title, not the BMC group as a whole. A newer or more specialized BMC journal may not yet carry every index a flagship title like BMC Medicine does.
Whether that journal carries a current Journal Impact Factor or CiteScore, if citation metrics matter for your purpose — these are assigned per journal by Clarivate and Elsevier respectively, not by publisher.
The named editorial board — BMC journals publish identifiable editors-in-chief and editorial board members with their institutional affiliations; this should be independently verifiable, not just asserted on the journal’s own marketing copy.
Retraction and correction transparency — a journal that issues and clearly labels corrections and retractions when warranted is demonstrating an active, functioning editorial process, not evidence of a problem.

None of this means treating an individual BMC title with more suspicion than the publisher as a whole warrants — it means applying the same specific, per-journal check to a BMC title that you should apply to any journal, at any publisher, before you submit to or cite it.

How to Check Any Publisher’s Legitimacy Yourself

The checks below work for BMC, and for any other publisher a researcher is unfamiliar with — this is the more durable skill than memorizing which specific publishers are “safe”:

DOAJ (Directory of Open Access Journals) — an independent, non-publisher-affiliated directory that only lists open-access journals meeting documented criteria: genuine open licensing, disclosed peer review, an identifiable editorial board, and a verifiable publishing track record. See CASRAI’s DOAJ entry. A journal’s DOAJ listing is a real, independently-vetted signal; its absence isn’t automatically disqualifying (DOAJ covers a large share of legitimate OA journals but not literally every one), but a listing is meaningful.
COPE (Committee on Publication Ethics) membership — publishers and journals that are COPE members have committed publicly to COPE’s Core Practices on peer review, authorship, and misconduct handling. See CASRAI’s COPE entry. Check membership on COPE’s own site rather than taking a publisher’s word for it.
Web of Science Master Journal List (mjl.clarivate.com) — Clarivate’s free, publicly searchable tool for checking whether a specific journal is currently indexed in Web of Science. CASRAI’s guide to the Master Journal List walks through how to use it. This is a stronger legitimacy signal than a publisher’s own claim of indexing, because Clarivate applies its own selection criteria and periodically delists titles that stop meeting them.
Beall’s List — useful history, unreliable as a current test. Jeffrey Beall, a University of Colorado Denver librarian, maintained a widely-cited list of what he classified as “potential, possible, or probable” predatory open-access publishers and journals from around 2010 until he took the list offline in January 2017. Unofficial, anonymously-run versions have circulated online since under similar names, but they are not maintained by Beall himself, are not independently vetted the way DOAJ inclusion or COPE membership is, and their current inclusion and exclusion criteria aren’t publicly documented the way DOAJ’s are. Treat any “Beall’s List” you encounter today as a historical reference point at best, not a maintained authority. CASRAI’s Beall’s List entry and comparison of DOAJ, Beall’s List, and Think.Check.Submit cover this in more depth.
Think.Check.Submit — a checklist-based tool built by a coalition of publishing organizations (including COPE, DOAJ, and OASPA) to help researchers evaluate an unfamiliar journal before submission, covering the same underlying questions — editorial board, indexing, fees, peer-review policy — in a structured format.

Applied to BMC: the publisher discloses its editorial process and ownership openly, its individual journals are indexed in the databases above, and Springer Nature (BMC’s parent company) participates in COPE and OASPA — all signals this checklist is designed to surface, and all independently verifiable rather than taken on the publisher’s own word.

How to Verify Peer Review Status for Any Journal

The BMC-specific facts above answer this one publisher’s case, but the more durable skill is knowing how to check any journal yourself. CASRAI’s How to Know If an Article Is Peer Reviewed guide walks through the concrete checks: journal website disclosure of review policy, indexing in recognized databases, editorial board verifiability, and publisher membership in COPE/OASPA/DOAJ. See also CASRAI’s guides on other frequently-questioned high-volume publishers — Is MDPI Peer Reviewed?, Is Frontiers Peer Reviewed?, Is Cureus Peer Reviewed?, and Is Taylor & Francis Peer Reviewed? — and the guide to identifying predatory journals and publishers, which covers the warning signs that distinguish a genuinely predatory operation from a legitimate publisher that simply has an unfamiliar name.

Frequently Asked Questions

Is BioMed Central the same as BMC?

Yes. “BMC” is the standard abbreviation for BioMed Central, both as the publisher name and as the naming prefix used for its journal series (BMC Medicine, BMC Public Health, and so on).

Is BMC owned by Springer Nature?

Yes. Springer Science+Business Media acquired BioMed Central in October 2008. When Springer merged with Macmillan Science and Education (Nature Publishing Group’s parent) in 2015 to form Springer Nature, BMC continued as a distinct publishing brand within the combined company.

Are all BMC journals indexed in PubMed and Web of Science?

Most of BMC’s established medicine and health-science titles are, but indexing is assessed and granted per journal, not for the publisher as a whole. Check the specific journal’s own indexing statement rather than assuming every BMC title carries identical coverage, especially for newer or more specialized titles.

Why does BMC’s name sound less familiar than other major publishers?

BMC was founded in 2000 under a descriptive name (“BioMed Central”) rather than a proper-noun brand, predating the more recent wave of APC-funded open-access publishers that copied a similar naming pattern without matching editorial rigor. The generic-sounding name is a historical naming artifact, not a reflection of BMC’s own editorial practices, which are well documented and independently verifiable.

Does BMC use open peer review?

Many of BMC’s medical journals do. In 2001, BioMed Central became the first publisher to post named peer reviewer reports alongside published articles as part of a “pre-publication history.” Policies vary by individual journal, so check the specific title’s peer-review policy page to confirm.

Are all BMC journals equally selective or high-quality?

No, and no large multi-journal publisher’s titles are. BMC’s several hundred journals vary in selectivity, editorial engagement, and citation impact, the same way titles from Springer Nature, Elsevier, or Wiley do. Check the specific journal’s peer-review policy, indexing status, and editorial board rather than assuming publisher-wide uniformity.

Should I use Beall’s List to check if a publisher is predatory?

Not as a sole or current test. The original Beall’s List, maintained by librarian Jeffrey Beall, was taken offline in January 2017; unofficial versions that circulate under similar names today aren’t maintained by Beall and aren’t independently vetted. Use DOAJ inclusion, COPE membership, and the Web of Science Master Journal List instead — these are actively maintained, independently verifiable checks.

Why did BioMed Central retract 43 papers?

In March 2015, BioMed Central retracted 43 articles after an investigation into fabricated peer review. Third-party agencies selling submission and language-editing services had supplied invented reviewer identities and contact addresses, so review requests reached the agency rather than a real academic. BMC disclosed the investigation, retracted the affected papers, and disabled the submission-system feature that had let authors enter reviewer contact details directly. It was a real integrity failure, detected and published by the publisher itself, and the loophole it exploited existed across the industry at the time.

What is BioMed Central’s impact factor?

There isn’t one. The Journal Impact Factor is calculated per journal by Clarivate, not per publisher, and BioMed Central publishes several hundred journals whose figures differ widely. Look up the specific BMC title in Journal Citation Reports rather than searching for a publisher-level number, and treat any source quoting “the BMC impact factor” as unreliable.

Is BioMed Central the same as Hindawi?

No. They are separate publishers with different owners: BioMed Central is part of Springer Nature, whereas Hindawi was acquired by Wiley. They are often mentioned in the same breath only because both are large, article-processing-charge-funded open-access publishers. The large-scale paper-mill retractions widely reported in 2023 and 2024 concerned Hindawi titles, not BMC ones — see CASRAI’s guide to Hindawi journal impact factors for what happened there.

Do I have to pay to publish in a BMC journal?

Usually yes. BMC is fully open access and funded by article processing charges rather than subscriptions. The charge is set per journal and published on that journal’s own site before submission, and many institutions hold agreements with Springer Nature that cover or discount it for corresponding authors. A published, pre-submission fee is normal for open access; a fee that only appears after acceptance is a predatory-journal warning sign.

Is BMC (BioMed Central) Peer Reviewed and Legit?

Ask about Is BMC (BioMed Central) Peer Reviewed and Legit?